Literature DB >> 32323555

European Bioanalysis Forum feedback on draft ICH M10 guideline on bioanalytical method validation during the Step 2b public consultation period.

Philip Timmerman1, Joanne Goodman2, Michaela Golob3, Tobias Haslberger4, Magnus Knutsson5, Robert Nelson6, Tom Verhaeghe7, Steve White8.   

Abstract

Once released, the ICH M10 Guideline on bioanalytical method validation will become one of the most important milestones in the history of regulated bioanalysis, closing a chapter on intense discussions among the industry and health authorities started in Crystal City in 2001. In this manuscript, the European Bioanalysis Forum community reports back on their feedback on the ICH M10 draft guideline gathered during the public consultation period. The comments given are intended to contribute to a guideline that combines several decades of experience and current scientific vision. They should provide future generations of bioanalytical scientist a regulatory framework so their bioanalytical work can contribute to safe, effective and high-quality medicines, which can be developed and registered in the most resource-efficient manner.

Entities:  

Keywords:  EBF; ICH M10; comments; harmonization; public consultation

Year:  2020        PMID: 32323555     DOI: 10.4155/bio-2020-0065

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  1 in total

1.  Validation of warfarin enantiomer analysis method in plasma using high-performance liquid chromatography fluorescence detector.

Authors:  Norisca Aliza Putriana; Taofik Rusdiana; Tina Rostinawati; Mohammad Rizki Akbar; Febrina Amelia Saputri; Siti Utami
Journal:  J Adv Pharm Technol Res       Date:  2022-01-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.